loadpatents
name:-0.078726053237915
name:-0.037953853607178
name:-0.011768102645874
Mi; Sha Patent Filings

Mi; Sha

Patent Applications and Registrations

Patent applications and USPTO patent grants for Mi; Sha.The latest application filed is for "sp35 antibodies and uses thereof".

Company Profile
9.41.68
  • Mi; Sha - Belmont MA
  • Mi; Sha - Cambridge MA
  • MI; Sha - US
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
SP35 Antibodies And Uses Thereof
App 20210395360 - Mi; Sha ;   et al.		2021-12-23
Lingo-1 Antagonists And Uses For Treatment Of Demyelinating Disorders
App 20210277111 - Cadavid; Diego ;   et al.		2021-09-09
Combination Therapies and Uses for Treatment of Demyelinating Disorders
App 20210260185 - Cadavid; Diego ;   et al.		2021-08-26
S1P modulating agents
Grant 10,894,040 - Thomas , et al. January 19, 2		2021-01-19
SP35 Antibodies And Uses Thereof
App 20200317775 - Mi; Sha ;   et al.		2020-10-08
Use Of Lingo-4 Antagonists In The Treatment Of Conditions Involving Demyelination
App 20200297800 - Mi; Sha ;   et al.		2020-09-24
Combination Therapies and Uses for Treatment of Demyelinating Disorders
App 20200276303 - Cadavid; Diego ;   et al.		2020-09-03
Lingo-1 Antagonists And Uses For Treatment Of Demyelinating Disorders
App 20200216533 - Cadavid; Diego ;   et al.		2020-07-09
S1p Modulating Agents
App 20200038385 - Thomas; Jermaine ;   et al.		2020-02-06
Lingo-2 Antagonists For Treatment Of Conditions Involving Motor Neurons
App 20190359706 - Mi; Sha ;   et al.		2019-11-28
LINGO-1 antagonists and uses for treatment of demyelinating disorders
Grant 10,435,467 - Cadavid , et al. O		2019-10-08
SIP modulating agents
Grant 10,406,144 - Thomas , et al. Sept		2019-09-10
SP35 Antibodies And Uses Thereof
App 20190161546 - Mi; Sha ;   et al.		2019-05-30
Use Of Lingo-4 Antagonists In The Treatment Of Conditions Involving Demyelination
App 20190060398 - Mi; Sha ;   et al.		2019-02-28
Combination Therapies and Uses for Treatment of Demyelinating Disorders
App 20190038744 - Cadavid; Diego ;   et al.		2019-02-07
S1p Modulating Agents
App 20180369215 - Thomas; Jermaine ;   et al.		2018-12-27
S1P modulating agents
Grant 10,034,869 - Thomas , et al. July 31, 2		2018-07-31
Lingo-1 Antagonists And Uses For Treatment Of Demyelinating Disorders
App 20180148505 - Cadavid; Diego ;   et al.		2018-05-31
Lingo-2 Antagonists For Treatment Of Conditions Involving Motor Neurons
App 20180111994 - Mi; Sha ;   et al.		2018-04-26
Compounds that are S1P modulating agents and/or ATX modulating agents
Grant 9,944,666 - Guckian , et al. April 17, 2		2018-04-17
S1p Modulating Agents
App 20180028511 - Thomas; Jermaine ;   et al.		2018-02-01
S1P modulating agents
Grant 9,808,449 - Thomas , et al. November 7, 2		2017-11-07
LINGO-2 antagonists for treatment of conditions involving motor neurons
Grant 9,796,780 - Mi , et al. October 24, 2		2017-10-24
Compositions comprising antibodies to LINGO or fragments thereof
Grant 9,745,375 - Mi , et al. August 29, 2		2017-08-29
Compounds That Are S1p Modulating Agents And/or Atx Modulating Agents
App 20170174710 - Guckian; Kevin M. ;   et al.		2017-06-22
Atx Modulating Agents
App 20170158687 - Guckian; Kevin M. ;   et al.		2017-06-08
SP35 Antibodies And Uses Thereof
App 20170037126 - Mi; Sha ;   et al.		2017-02-09
ATX modulating agents
Grant 9,555,050 - Guckian , et al. January 31, 2		2017-01-31
Compounds that are S1P modulating agents and/or ATX modulating agents
Grant 9,550,798 - Guckian , et al. January 24, 2		2017-01-24
Compositions Comprising Antibodies to Lingo or Fragments Thereof
App 20160368984 - Mi; Sha ;   et al.		2016-12-22
ATX modulating agents
Grant 9,522,889 - Guckian , et al. December 20, 2		2016-12-20
Methods for Treating Pressure Induced Optic Neuropathy, Preventing Neuronal Degeneration and Promoting Neuronal Cell Survival Via Administration of Lingo-1 Antagonists and TrkB Agonists
App 20160354465 - Mi; Sha		2016-12-08
S1P modulating agents
App 20160263093 - Thomas; Jermaine ;   et al.		2016-09-15
Use Of Lingo-4 Antagonists In The Treatment Of Conditions Involving Demyelination
App 20160213745 - Mi; Sha ;   et al.		2016-07-28
S1P modulating agents
Grant 9,340,527 - Thomas , et al. May 17, 2		2016-05-17
Compositions Comprising Antibodies to Lingo or Fragments Thereof
App 20160083468 - Mi; Sha ;   et al.		2016-03-24
Treatment Of Conditions Involving Demyelination
App 20160002329 - Mi; Sha ;   et al.		2016-01-07
Use of DR6 Antagonists to Improve Motor Neuron Disease
App 20150329638 - MI; Sha		2015-11-19
SP35 Antibodies And Uses Thereof
App 20150315273 - Mi; Sha ;   et al.		2015-11-05
Atx Modulating Agents
App 20150246063 - Guckian; Kevin ;   et al.		2015-09-03
Combination Therapies And Uses For Treatment Of Demyelinating Disorders
App 20150238602 - Cadavid; Diego ;   et al.		2015-08-27
Use of semaphorin 6A for promoting myelination and oligodendrocyte differentiation
Grant 9,107,884 - Chedotal , et al. August 18, 2		2015-08-18
Atx Modulating Agents
App 20150210647 - Guckian; Kevin ;   et al.		2015-07-30
Compounds That Are S1p Modulating Agents And/or Atx Modulating Agents
App 20150203515 - Guckian; Kevin ;   et al.		2015-07-23
Use of DR6 and p75 Antagonists to Promote Survival of Cells of the Nervous System
App 20150203585 - MI; Sha ;   et al.		2015-07-23
Screening methods for identifying Sp35 antagonists
Grant 9,068,992 - Mi , et al. June 30, 2		2015-06-30
Sp35 antibodies and uses thereof
Grant 9,066,984 - Mi , et al. June 30, 2		2015-06-30
Nogo Receptor Binding Protein
App 20150177240 - Mi; Sha ;   et al.		2015-06-25
Lingo-2 Antagonists For Treatment Of Conditions Involving Motor Neurons
App 20150118241 - Mi; Sha ;   et al.		2015-04-30
NOGO receptor binding protein
Grant 8,932,821 - Mi , et al. January 13, 2		2015-01-13
S1P Modulating Agents
App 20140371209 - Thomas; Jermaine ;   et al.		2014-12-18
Use of DR6 and p75 antagonists to promote survival of cells of the nervous system
Grant 8,894,999 - Mi , et al. November 25, 2		2014-11-25
Sp35 Antibodies and Uses Thereof
App 20140199315 - MI; Sha ;   et al.		2014-07-17
NOGO receptor binding protein
Grant 8,765,662 - Mi , et al. July 1, 2		2014-07-01
Methods for promoting myelination, neuronal survival and oligodendrocyte differentiation via administration of Sp35 or TrkA antagonists
Grant 8,642,040 - Mi , et al. February 4, 2		2014-02-04
Use of DR6 and p75 Antagonists to Promote Survival of Cells of the Nervous System
App 20140010826 - MI; Sha ;   et al.		2014-01-09
Sp35 Antibodies and Uses Thereof
App 20130336991 - MI; Sha ;   et al.		2013-12-19
Sp35 antibodies and uses thereof
Grant 8,609,407 - Mi , et al. December 17, 2		2013-12-17
Composition Comprising Antibodies to LINGO or Fragments Thereof
App 20130323786 - MI; Sha ;   et al.		2013-12-05
Sp35 Antibodies and Uses Thereof
App 20130287796 - MI; Sha ;   et al.		2013-10-31
NOGO Receptor Binding Protein
App 20130287693 - MI; SHA ;   et al.		2013-10-31
Treatment of Conditions Involving Demyelination
App 20130273558 - MI; Sha ;   et al.		2013-10-17
SP35 antibodies and uses thereof
Grant 8,551,476 - Mi , et al. October 8, 2		2013-10-08
Use of DR6 and p75 antagonists to promote survival of cells of the nervous system
Grant 8,501,178 - Mi , et al. August 6, 2		2013-08-06
Treatment of conditions involving demyelination
Grant 8,486,893 - Mi , et al. July 16, 2		2013-07-16
Composition comprising antibodies to LINGO or fragments thereof
Grant 8,425,910 - Mi , et al. April 23, 2		2013-04-23
NOGO Receptor Binding Protein
App 20120230979 - MI; Sha ;   et al.		2012-09-13
Sp35 Antibodies and Uses Thereof
App 20120190070 - MI; Sha ;   et al.		2012-07-26
Use of DR6 and p75 Antagonists to Promote Survival of Cells of the Nervous System
App 20120141456 - Mi; Sha ;   et al.		2012-06-07
Nogo receptor binding protein
Grant 8,153,580 - Mi , et al. April 10, 2		2012-04-10
Sp35 antibodies and uses thereof
Grant 8,128,926 - Mi , et al. March 6, 2		2012-03-06
Composition Comprising Antibodies to LINGO or Fragments Thereof
App 20120014960 - MI; Sha ;   et al.		2012-01-19
Sp35 Antibodies and Uses Thereof
App 20110311542 - MI; SHA ;   et al.		2011-12-22
Composition comprising antibodies to LINGO or fragments thereof
Grant 8,058,406 - Mi , et al. November 15, 2		2011-11-15
Use of LINGO-4 Antagonists in the Treatment of Conditions Involving Demyelination
App 20110123553 - Mi; Sha ;   et al.		2011-05-26
TAJ in Neuronal Function
App 20110052500 - Mi; Sha ;   et al.		2011-03-03
Methods of promoting neurite outgrowth with soluble TAJ polypeptides
Grant 7,846,438 - Mi , et al. December 7, 2		2010-12-07
Methods for Treating Pressure Induced Optic Neuropathy, Preventing Neuronal Degeneration and Promoting Neuronal Cell Survival Via Administration of LINGO-1 Antagonists and TrkB Agonists
App 20100297121 - Mi; Sha		2010-11-25
Nogo receptor binding protein
Grant 7,785,829 - Mi , et al. August 31, 2		2010-08-31
NOGO Receptor Binding Protein
App 20100204304 - Mi; Sha ;   et al.		2010-08-12
Use of Semaphorin 6A for Promoting Myelination and Oligodendrocyte Differentiation
App 20100189713 - Chedotal; Alain ;   et al.		2010-07-29
Methods for Promoting Myelination, Neuronal Survival and Oligodendrocyte Differentiation Via Administration of SP35 or TrkA Antagonists
App 20100074907 - Mi; Sha ;   et al.		2010-03-25
Composition Comprising Antibodies to LINGO or Fragments Thereof
App 20100015131 - MI; Sha ;   et al.		2010-01-21
Sp35 Antibodies and Uses Thereof
App 20090252748 - MI; Sha ;   et al.		2009-10-08
Methods for Promoting Neurite Outgrowth and Survival of Dopaminergic Neurons
App 20090246189 - Mi; Sha ;   et al.		2009-10-01
Treatment of Conditions Involving Demyelination
App 20090175872 - Mi; Sha ;   et al.		2009-07-09
Oligodendrocyte-Myelin Glycoprotein Compositions and Methods of Use Thereof
App 20090175846 - Mi; Sha ;   et al.		2009-07-09
Human Il-17f And Other Il-17f-related Proteins And Methods Related Thereto
App 20090075884 - Jacobs; Kenneth ;   et al.		2009-03-19
SP35 Antibodies and uses thereof
App 20090017039 - Mi; Sha ;   et al.		2009-01-15
Nogo receptor binding protein
App 20070059793 - Mi; Sha ;   et al.		2007-03-15
TAJ in neuronal function
App 20060058223 - Mi; Sha ;   et al.		2006-03-16
Treatment of conditions involving demyelination
App 20060009388 - Mi; Sha ;   et al.		2006-01-12
Antibodies to human IL-17F and other CTLA-8-related proteins and methods related thereto
App 20050214315 - Jacobs, Kenneth ;   et al.		2005-09-29
Antibodies to human IL-17F and other CTLA-8-related proteins
Grant 6,902,735 - Jacobs , et al. June 7, 2		2005-06-07
Secreted proteins and polynucleotides encoding them
App 20030100053 - Jacobs, Kenneth ;   et al.		2003-05-29
Methods and compositions for diagnosing and treating preeclampsia and gestational trophoblast disorders
App 20020102530 - Keith, James C. JR. ;   et al.		2002-08-01
Polynucleotides encoding human CTLA-8 related proteins
Grant 6,074,849 - Jacobs , et al. June 13, 2		2000-06-13
Human CTLA-8 and uses of CTLA-8-related proteins
Grant 6,043,344 - Jacobs , et al. March 28, 2		2000-03-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed